Christopher W. Fulton

Array ( [id] => 5913547 [patent_doc_number] => 20060128609 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-15 [patent_title] => 'N¹- modified glycopeptides' [patent_app_type] => utility [patent_app_number] => 11/219523 [patent_app_country] => US [patent_app_date] => 2005-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4927 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20060128609.pdf [firstpage_image] =>[orig_patent_app_number] => 11219523 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5015815 [patent_doc_number] => 20070259024 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-08 [patent_title] => 'Composition and Method for Prevention or Treatment of Stomatitis' [patent_app_type] => utility [patent_app_number] => 11/574682 [patent_app_country] => US [patent_app_date] => 2005-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4866 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0259/20070259024.pdf [firstpage_image] =>[orig_patent_app_number] => 11574682 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5904440 [patent_doc_number] => 20060046956 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-02 [patent_title] => 'Acylsulfonamide compounds as inhibitors of hepatitis C virus NS3 serine protease' [patent_app_type] => utility [patent_app_number] => 11/211771 [patent_app_country] => US [patent_app_date] => 2005-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16443 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20060046956.pdf [firstpage_image] =>[orig_patent_app_number] => 11211771 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5904488 [patent_doc_number] => 20060046966 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-02 [patent_title] => 'Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis' [patent_app_type] => utility [patent_app_number] => 11/210717 [patent_app_country] => US [patent_app_date] => 2005-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44623 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20060046966.pdf [firstpage_image] =>[orig_patent_app_number] => 11210717 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5828851 [patent_doc_number] => 20060063701 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-23 [patent_title] => 'Methods and compositions for modulating C5-a-mediated inflammatory responses' [patent_app_type] => utility [patent_app_number] => 11/202449 [patent_app_country] => US [patent_app_date] => 2005-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8431 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20060063701.pdf [firstpage_image] =>[orig_patent_app_number] => 11202449 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5649799 [patent_doc_number] => 20060135534 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => 'Pyrazine based inhibitors of glycogen synthase kinase 3' [patent_app_type] => utility [patent_app_number] => 11/202013 [patent_app_country] => US [patent_app_date] => 2005-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14906 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20060135534.pdf [firstpage_image] =>[orig_patent_app_number] => 11202013 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5760658 [patent_doc_number] => 20060211603 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-21 [patent_title] => 'Ramoplanin derivatives possessing antibacterial activity' [patent_app_type] => utility [patent_app_number] => 11/198763 [patent_app_country] => US [patent_app_date] => 2005-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 63741 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20060211603.pdf [firstpage_image] =>[orig_patent_app_number] => 11198763 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 299986 [patent_doc_number] => 07538187 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-05-26 [patent_title] => 'Coloring compositions with peptide-based dispersants and binders' [patent_app_type] => utility [patent_app_number] => 11/194834 [patent_app_country] => US [patent_app_date] => 2005-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10809 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/538/07538187.pdf [firstpage_image] =>[orig_patent_app_number] => 11194834 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4960687 [patent_doc_number] => 20080275112 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-06 [patent_title] => 'Invention Concerning Aminoadamantane Compounds' [patent_app_type] => utility [patent_app_number] => 11/658172 [patent_app_country] => US [patent_app_date] => 2005-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 18693 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20080275112.pdf [firstpage_image] =>[orig_patent_app_number] => 11658172 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4540926 [patent_doc_number] => 07875700 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-01-25 [patent_title] => 'Cation complexes of insulin compound conjugates, formulation and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/184668 [patent_app_country] => US [patent_app_date] => 2005-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 56776 [patent_no_of_claims] => 82 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/875/07875700.pdf [firstpage_image] =>[orig_patent_app_number] => 11184668 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4534741 [patent_doc_number] => 07872095 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-01-18 [patent_title] => 'Insulin-oligomer conjugates, formulations and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/184594 [patent_app_country] => US [patent_app_date] => 2005-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 56818 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/872/07872095.pdf [firstpage_image] =>[orig_patent_app_number] => 11184594 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5766682 [patent_doc_number] => 20060018874 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-26 [patent_title] => 'Fatty acid formulations for oral delivery of proteins and peptides, and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/184528 [patent_app_country] => US [patent_app_date] => 2005-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 56868 [patent_no_of_claims] => 111 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20060018874.pdf [firstpage_image] =>[orig_patent_app_number] => 11184528 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5142400 [patent_doc_number] => 20070004616 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-04 [patent_title] => 'GLP-1 pharmaceutical compositions' [patent_app_type] => utility [patent_app_number] => 11/173744 [patent_app_country] => US [patent_app_date] => 2005-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10886 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20070004616.pdf [firstpage_image] =>[orig_patent_app_number] => 11173744 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5710957 [patent_doc_number] => 20060052302 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-09 [patent_title] => 'Polymer factor IX moiety conjugates' [patent_app_type] => utility [patent_app_number] => 11/172459 [patent_app_country] => US [patent_app_date] => 2005-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 22291 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20060052302.pdf [firstpage_image] =>[orig_patent_app_number] => 11172459 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5142424 [patent_doc_number] => 20070004640 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-04 [patent_title] => 'Treatment of dry eye' [patent_app_type] => utility [patent_app_number] => 11/171785 [patent_app_country] => US [patent_app_date] => 2005-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4748 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20070004640.pdf [firstpage_image] =>[orig_patent_app_number] => 11171785 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 82189 [patent_doc_number] => 07745575 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2010-06-29 [patent_title] => 'OsK1 derivatives' [patent_app_type] => utility [patent_app_number] => 11/571005 [patent_app_country] => US [patent_app_date] => 2005-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3719 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/745/07745575.pdf [firstpage_image] =>[orig_patent_app_number] => 11571005 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 917589 [patent_doc_number] => 07323543 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-01-29 [patent_title] => 'Multiple agent diabetes therapy' [patent_app_type] => utility [patent_app_number] => 11/166390 [patent_app_country] => US [patent_app_date] => 2005-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2973 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/323/07323543.pdf [firstpage_image] =>[orig_patent_app_number] => 11166390 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5602882 [patent_doc_number] => 20060293227 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-28 [patent_title] => 'Cosmetic compositions and methods using transforming growth factor-beta mimics' [patent_app_type] => utility [patent_app_number] => 11/166259 [patent_app_country] => US [patent_app_date] => 2005-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 20418 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20060293227.pdf [firstpage_image] =>[orig_patent_app_number] => 11166259 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 408301 [patent_doc_number] => 07285619 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-10-23 [patent_title] => 'Echinocandin derivatives, their method of preparation and their application as anti-fungal agents' [patent_app_type] => utility [patent_app_number] => 11/165458 [patent_app_country] => US [patent_app_date] => 2005-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5756 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/285/07285619.pdf [firstpage_image] =>[orig_patent_app_number] => 11165458 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6926455 [patent_doc_number] => 20050239711 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-27 [patent_title] => 'Selective linear peptides with melanocortin-4 receptor (MC4-R) agonist activity' [patent_app_type] => utility [patent_app_number] => 11/159007 [patent_app_country] => US [patent_app_date] => 2005-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 64478 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20050239711.pdf [firstpage_image] =>[orig_patent_app_number] => 11159007 [rel_patent_id] =>[rel_patent_doc_number] =>)